Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DRISCOLL, LORA E BARNHART | 1 | 31.7% | +20.3% |
| SKELDING, ZACHARY S | 1 | 59.8% | +41.0% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| LUNDE, GRACE HENRY | 1 | 63.0% | +38.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264191 | THERAPEUTIC COMBINATION AND USE THEREOF | DRISCOLL, LORA E BARNHART | 28d overdue |
| 18250010 | ANTI-CD73 ANTIBODY AND USE THEREOF | SKELDING, ZACHARY S | — |
| 18024471 | ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF | AEDER, SEAN E | — |
| 17630467 | ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND USES THEREOF | LUNDE, GRACE HENRY | — |
| Art Unit | Apps |
|---|---|
| 3991 | 1 |
| 1644 | 1 |
| 1642 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18264191 | THERAPEUTIC COMBINATION AND USE THEREOF | DRISCOLL, LORA E BARNHART | 3991 | §103 | Final Rejection | 28d overdue | Pending | Aug 03, 2023 |
| 18250010 | ANTI-CD73 ANTIBODY AND USE THEREOF | SKELDING, ZACHARY S | 1644 | §102§112DP | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18024471 | ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF | AEDER, SEAN E | 1642 | §103DPOther | Final Rejection | — | Pending | Mar 02, 2023 |
| 17630467 | ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND USES THEREOF | LUNDE, GRACE HENRY | 1641 | §102§103§112DP | Non-Final OA | — | Pending | Jan 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial